A. Jo Chien

8.3k citations

94 papers · 2.1k indexed · 1 hit paper · h-index 23

Impact in

Reproductive Medicine top 1%
- Ovarian function and disorders
- Reproductive Health and Technologies
Oncology top 2%
- Cancer Risks and Factors
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research

Papers in

Oncology 64
- HER2/EGFR in Cancer Research 25
- Cancer Treatment and Pharmacology 17
- Cancer Risks and Factors 8
- Cancer Immunotherapy and Biomarkers 8
Cancer Research 24
- Breast Cancer Treatment Studies 19

Co-authors: Michelle Melisko Hope S. Rugo Mitchell P. Rosen Joseph M. Letourneau Marcelle I. Cedars Patricia Katz E. Ebbel Mark M. Moasser
Journals: Journal of Clinical Oncology (38 papers)Breast Cancer Research and Treatment (16 papers)npj Breast Cancer (7 papers)Clinical Cancer Research (4 papers)Cancer Research (4 papers)
Partner nations: United States Australia Spain

In The Last Decade

A. Jo Chien

88 papers receiving 2.1k citations

Hit Papers

align trajectories log scale

Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer 2011 · 406 citations

Peers

Countries citing papers authored by A. Jo Chien

Since Specialization

Citations

This map shows the geographic impact of A. Jo Chien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Jo Chien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Jo Chien more than expected).

Fields of papers citing papers by A. Jo Chien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Jo Chien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Jo Chien. The network helps show where A. Jo Chien may publish in the future.

Co-authors

The 25 scholars most cited alongside A. Jo Chien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Jo Chien Line = papers co-authored together A. Jo Chien links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC): Updated data and subgroup analyses by age, sites of disease, and use of intervening therapies. Journal of Clinical Oncology ·Laura A. Huppert, Reshma Mahtani, William D. Furley, Naomi Dempsey, Melanie C. Green, Mujtaba A. Fliayyh, Saya Jacob, Carlos A. Mellado Fritz, Michelle Melisko, A. Jo Chien, Owokola Motunrayo Victoria, Lauren Carcas, Manmeet S. Ahluwalia, F. L. Ivanchenko, Nurul Khotimah, Damé Idossa, Ruta Rao, Karthik V. Giridhar, Hope S. Rugo	2024	7
2	Rates of pathologic complete response (pCR)after neoadjuvant datopotamab deruxtecan (Dato): Results from the I-SPY2.2 trial. Journal of Clinical Oncology ·Jane Meisel, Katia Khoury, A. Jo Chien, Anne M. Wallace, Chester Gillis, Сергиенко Ирина Александровна, Nicole Williams, Rita Nanda, Virginia F. Borges, Erica Stringer-Reasor, Judy C. Boughey, Chaitali Nangia, Christos Vaklavas, L. Dayu, Angela DeMichele, Nola Hylton, Douglas Yee, Christina Yau, Laura J. Esserman, (unknown)	2024	4
3	Synchronous or metachronous breast and colorectal cancers in younger-than-average-age patients: a case series The Oncologist ·Amanda S. Bluem, Francis Wright, 齊學平, A. Jo Chien, Jasmine Wong, John W. Park, Amie Blanco, Katherine Van Loon, Chloé E. Atreya	2024	1
4	Impact of Systemic Therapy on Fertility in Women with Early-Stage Breast Cancer Current Breast Cancer Reports ·R Kratzsch, A. Jo Chien	2024	3
5	Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy Breast Cancer Research and Treatment ·Saya Jacob, Миновский Юрий Петрович, William D. Furley, 何星, Paras Nazir, Hongmei Yu, Gillian L. Hirst, Hatem Soliman, Rita Nanda, Rita A. Mukhtar, B. S. Min, Melanie Majure, Michelle Melisko, Hope S. Rugo, Laura J. Esserman, Elissa R. Price, A. Jo Chien	2024	1
6	The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database (NCDB) Breast Cancer Research and Treatment ·Harriet Rothschild, Jane Alexopoulous, Mary Kathryn Abel, A. Jo Chien, Amy M. Shui, Laura J. Esserman, Seema A. Khan, Rita A. Mukhtar	2023	2
7	Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes Breast Cancer Research and Treatment ·Jane Alexopoulous, Harriet Rothschild, Stein Us i, Lu Zhaofu, Eleftheria Tragoulia, W. Fraser Symmans, Christopher J. Schwartz, A. Jo Chien, Christopher C. Benz, Rita A. Mukhtar	2023	1
8	A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer Breast Cancer Research and Treatment ·Özge Gümüşay, Laura A. Huppert, Mark Jesus M. Magbanua, F Kiani Ndeh, F. Frasincar, A. Jo Chien, Michelle Melisko, Melanie Majure, Mark M. Moasser, John Park, Hope S. Rugo	2023	1
9	Clinical characteristics and outcomes in patients with metastatic breast cancer and pseudocirrhosis: a single center retrospective cohort study Breast Cancer Research and Treatment ·Laura A. Huppert, Zak Walker, Yoshio TUBOYAMA, Mi‐Ok Kim, Ali Shaban, Danielle Brandman, Melanie Majure, Michelle Melisko, Hope S. Rugo, Spencer C. Behr, A. Jo Chien	2022	7
10	Molecular subtype to predict pathologic complete response in HER2-positive breast cancer in the I-SPY2 trial. Journal of Clinical Oncology ·Alexandra Thomas, Amy S. Clark, Christina Yau, Denise M. Wolf, Laura van ‘t Veer, Makoto KAGAYA, A. Jo Chien, Laura A. Huppert, Hope S. Rugo, Rebecca Shatsky, Claudine Isaacs, Donald A. Berry, Douglas Yee, Angela DeMichele, Laura J. Esserman	2022	1
11	Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk npj Breast Cancer ·Mark Jesus M. Magbanua, Wen Li, Denise M. Wolf, Christina Yau, Gillian L. Hirst, Lamorna Brown Swigart, J. Nilz, Jessica Gibbs, Amy L. Delson, Ekaterina Kalashnikova, Alexey Aleshin, Bernhard Zimmermann, A. Jo Chien, Debu Tripathy, Laura J. Esserman, Nola M. Hylton, Laura van ‘t Veer	2021	33
12	Concomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) randomized clinical trial Journal of Assisted Reproduction and Genetics ·米赛良, W.C.R. Fernando, 张建礼, Salustiano Ribeiro, Ange Wang, Charles E. McCulloch, Evelyn Mok-Lin, Marek Doležal, A. Jo Chien, Marcelle I. Cedars, Mitchell P. Rosen	2021	15
13	Multidisciplinary Management of Cancer During Pregnancy JCO Oncology Practice ·Amanda S. Bluem, K. Ramesh, A. Jo Chien, Rebecca L. Olin, Katy K. Tsai, O. Paradela F.°, Katherine Van Loon	2020	54
14	Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer Nature Communications ·Manuela Terranova-Barberio, Nela Pawłowska, Mallika Dhawan, Mark M. Moasser, A. Jo Chien, Michelle Melisko, Hope S. Rugo, Ilham Prayogi, I-Ling Ho, Adil Daud, Michael D. Rosenblum, Scott Thomas, Pamela N. Münster	2020	119
15	Mechanism of action biomarkers predicting response to AKT inhibition in the I-SPY 2 breast cancer trial npj Breast Cancer ·Denise M. Wolf, Christina Yau, Julia Wulfkuhle, Lamorna Brown Swigart, Rosa I. Gallagher, Mark Jesus M. Magbanua, 金明飞, Gillian L. Hirst, (unknown), Smita Asare, Debu Tripathy, Don Berry, Laura J. Esserman, A. Jo Chien, Emanuel F. Petricoin, Laura van ‘t Veer	2020	25
16	Fitbit Usage in Patients With Breast Cancer Undergoing Chemotherapy Clinical Breast Cancer ·Taís Ferri, Edward Hadeler, Sheri J. Hartman, Adline Jancy Y, Irene Acerbi, Hope S. Rugo, Melanie Majure, A. Jo Chien, Laura J. Esserman, Michelle Melisko	2019	22
17	Differential Toxicity in Patients with and without DNA Repair Mutations: Phase I Study of Carboplatin and Talazoparib in Advanced Solid Tumors Clinical Cancer Research ·Yves Tshitoko, Imke H. Bartelink, Rahul Aggarwal, Jim Leng, Z Hajatpour, Nela Pawłowska, Manuela Terranova-Barberio, Jennifer A. Grabowsky, Carolina Jiménez, A. Jo Chien, Mark M. Moasser, Robin Kate Kelley, Daniel Bergeron, Scott Thomas, Pamela N. Münster	2017	58
18	Pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer (BC): Results from I-SPY 2. Journal of Clinical Oncology ·Rita Nanda, Minetta C. Liu, Christina Yau, Smita Asare, Nola Hylton, Laura van’t Veer, Jane Perlmutter, Anne M. Wallace, A. Jo Chien, Andres Forero‐Torres, Erin D. Ellis, Heather Han, Amy S. Clark, Kathy S. Albain, Judy C. Boughey, Anthony Elias, Donald A. Berry, Douglas Yee, Angela DeMichele, Laura Esserman	2017	158
19	Adaptively randomized trial of neoadjuvant chemotherapy with or without the Akt inhibitor MK-2206: Graduation results from the I-SPY 2 Trial. Journal of Clinical Oncology ·Debu Tripathy, A. Jo Chien, Nola M. Hylton, Meredith Buxton, Toya Nath Upadhyay, Anne M. Wallace, Andres Forero, Henry G. Kaplan, Rita Nanda, Kathy S. Albain, Stacy L. Moulder, Barbara Haley, Angela DeMichele, W. Fraser Symmans, Laura van ‘t Veer, Melissa Paoloni, Laura J. Esserman, Donald A. Berry, Douglas Yee	2015	23
20	The cardiac safety of trastuzumab in the treatment of breast cancer Expert Opinion on Drug Safety ·A. Jo Chien, Hope S. Rugo	2010	48

About A. Jo Chien

A. Jo Chien is a scholar working on Oncology, Cancer Research, Genetics, Reproductive Medicine and Pulmonary and Respiratory Medicine, having authored 94 papers that have together received 2.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (25 papers), Breast Cancer Treatment Studies (19 papers), Cancer Treatment and Pharmacology (17 papers), Advanced Breast Cancer Therapies (15 papers), Chronic Lymphocytic Leukemia Research (12 papers), Cancer Risks and Factors (8 papers), Reproductive Biology and Fertility (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). The work is most often cited by research in Reproductive Medicine (572 citations), Oncology (1.1k citations), Public Health, Environmental and Occupational Health (707 citations), Cancer Research (296 citations) and Pediatrics, Perinatology and Child Health (243 citations). A. Jo Chien has collaborated with scholars based in United States, Australia and Spain. Frequent co-authors include Michelle Melisko, Hope S. Rugo, Mitchell P. Rosen, Joseph M. Letourneau, Marcelle I. Cedars, Patricia Katz, E. Ebbel, Mark M. Moasser, Paul E. Goss and A. Katz. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, npj Breast Cancer, Clinical Cancer Research and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact